EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-22 promotes mucin-type O-glycosylation and MATH1+ cell-mediated amelioration of intestinal inflammation

Ankita Singh, Michael Beaupre, Cecilia Villegas-Novoa, Kiyoshi Shiomitsu, Stephen J Gaudino, Suzanne Tawch, Ruhee Damle, Cody Kempen, Biswa Choudhury, Jeremy P McAleer, Brian S Sheridan, Paula Denoya und 4 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Ankita Singh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Colitis, Glycosylation, Interleukin-22, Interleukins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisGlycosylationInterleukin-22InterleukinsReceptors, InterleukinAnimalsHumansMiceBasic Helix-Loop-Helix ProteinsDextran SulfateGalactosyltransferasesInflammationIntestinal MucosaMice, Inbred C57BLMice, KnockoutMucinsSignal TransductionStem Cells

Stichwörter der Autor:innen

B3GALT5CP: ImmunologyIL-22IL-22Ra1MATH1O-glycanSTAT3colitisepitheliummucinregeneration

Substanzen

Basic Helix-Loop-Helix ProteinsDextran SulfateGalactosyltransferasesInterleukin-22InterleukinsMucinsReceptors, InterleukinAtoh1 protein, mouseinterleukin-22 receptorIL22 protein, human

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
  • Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.
  • GlycoAnalytics Core, University of California, San Diego, La Jolla, CA 92093, USA.
  • Department of Pharmaceutical Sciences, Marshall University School of Pharmacy, Huntington, WV 25701, USA.
  • Division of Colon and Rectal Surgery, Department of Surgery, Stony Brook University Hospital, Stony Brook, NY 11794, USA.
  • Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NCI NIH HHS
  • Crohn's and Colitis Foundation of America
  • California Community Foundation
  • National Institutes of Health
  • NIDDK
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research

Zitieren

APA

Singh, A., Beaupre, M., Villegas-Novoa, C., Shiomitsu, K., Gaudino, S. J., Tawch, S., Damle, R., Kempen, C., Choudhury, B., McAleer, J. P., Sheridan, B. S., Denoya, P., Blumberg, R. S., Hearing, P., Allbritton, N. L., & Kumar, P. (2024). IL-22 promotes mucin-type O-glycosylation and MATH1+ cell-mediated amelioration of intestinal inflammation. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114206

Vancouver

Singh A, Beaupre M, Villegas-Novoa C, Shiomitsu K, Gaudino SJ, Tawch S, et al. IL-22 promotes mucin-type O-glycosylation and MATH1+ cell-mediated amelioration of intestinal inflammation. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114206

BibTeX
@article{Singh2024,
  author = {Singh, Ankita and Beaupre, Michael and Villegas-Novoa, Cecilia and Shiomitsu, Kiyoshi and Gaudino, Stephen J and Tawch, Suzanne and Damle, Ruhee and Kempen, Cody and Choudhury, Biswa and McAleer, Jeremy P and Sheridan, Brian S and Denoya, Paula and Blumberg, Richard S and Hearing, Patrick and Allbritton, Nancy L and Kumar, Pawan},
  title = {IL-22 promotes mucin-type O-glycosylation and MATH1+ cell-mediated amelioration of intestinal inflammation},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114206}
}
Kostenlos starten →